Form 4: NeuroOne Medical Technologies Officer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 1,158 shares of common stock on June 30, 2024, to satisfy tax withholding obligations.
Summary
- On June 30, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 1,158 shares of common stock.
- The transaction was executed to cover tax withholding obligations arising from equity compensation.
- The shares were disposed of at a price of $0.8 per share.
- Following the transaction, Mertens directly owns 174,999 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock disposal for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small number of shares being disposed of by an officer to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of transaction: disposal of shares |
| 07/02/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.